Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × apatinib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Genitourinary 1

Conditions

Metastatic Castration Resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 6 Radiosurgery 5 Docetaxel 4 enzalutamide 3 Radiotherapy 3 Everolimus 3 Androgen Antagonists 3 relugolix 2 luprolide acetate gel depot 2 darolutamide 2 Surveys and Questionnaires 2 Standard of Care 2 Radiofrequency Ablation 2 Panobinostat 2 Leuprolide 2 Abiraterone Acetate 2 trastuzumab deruxtecan 1 talazoparib 1 spartalizumab 1 siremadlin 1 sipuleucel-T 1 sargramostim 1 resiquimod 1 poly ICLC 1 olaparib 1 liposomal doxorubicin 1 ixabepilone 1 gallium 68 PSMA-11 1 apatinib 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407976 2020-07-15

APPEASE

University of Utah

Phase 1 Terminated

Adenocarcinoma, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡